Exane Derivatives’s Akamai AKAM Stock Holding History

Exane Derivatives’s Portfolio AKAM Stock Details AKAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$47.1K	Sell	516 -2,609	-83%	-$272K	0.03%	315
2022 Q1	$373K	Buy	3,125 +10	+0.3%	+$1.12K	0.11%	222
2021 Q4	$365K	Buy	3,115 +2,663	+589%	+$293K	0.09%	225
2021 Q3	$47.3K	Sell	452 -142	-24%	-$16.2K	0.01%	620
2021 Q2	$68.4K	Sell	594 -16	-3%	-$1.78K	0.02%	592
2021 Q1	$62.2K	Sell	610 -6,910	-92%	-$713K	0.02%	498
2020 Q4	$790K	Sell	7,520 -4,919	-40%	-$515K	0.23%	106
2020 Q3	$1.38M	Buy	12,439 +3,725	+43%	+$413K	0.4%	53
2020 Q2	$933K	Buy	8,714 +8,700	+62,143%	+$875K	0.25%	89
2020 Q1	$1.28K	Hold	14	–	–	﹤0.01%	528
2019 Q4	$1.33K	Sell	14 -7,025	-100%	-$614K	﹤0.01%	523
2019 Q3	$643K	Sell	7,039 -2,295	-25%	-$199K	0.12%	140
2019 Q2	$748K	Buy	9,334 +9,205	+7,136%	+$712K	0.13%	126
2019 Q1	$9.25K	Sell	129 -1,258	-91%	-$85.3K	﹤0.01%	395
2018 Q4	$84.7K	Hold	1,387	–	–	0.02%	331
2018 Q3	$101K	Buy	+1,387	New	+$104K	0.02%	315
2017 Q1	–	Sell	-221	Closed	-$14.7K	–	574
2016 Q4	$14.7K	Hold	221	–	–	﹤0.01%	385
2016 Q3	$11.7K	Hold	221	–	–	﹤0.01%	388
2016 Q2	$12.4K	Buy	221 +106	+92%	+$5.58K	﹤0.01%	359
2016 Q1	$6.39K	Buy	115 +43	+60%	+$2.19K	﹤0.01%	432
2015 Q4	$3.79K	Buy	+72	New	+$4.42K	﹤0.01%	370

Other funds holding AKAM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exane Derivatives's AKAM Position: Q2 2022 in Review

Exane Derivatives reduced its Akamai (AKAM) stake by 83% in Q2 2022, selling an estimated $272K and leaving 516 shares worth $47.1K. The position accounts for 0.03% of the portfolio, ranked #315.

Exane Derivatives first reported a position in AKAM in Q4 2015 and has held it in 21 quarters since. The position peaked at $1.38M in Q3 2020. 695 funds tracked by Wall St. Rank hold AKAM as of Q2 2022.

Exane Derivatives held 516 shares of Akamai worth $47.1K as of Q2 2022.
Exane Derivatives sold 2,609 Akamai shares in Q2 2022, an estimated $272K.
Akamai made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #315 holding.
Exane Derivatives first reported a position in Akamai in Q4 2015 and has held it in 21 quarters since.
Exane Derivatives's Akamai position peaked at $1.38M in Q3 2020.
695 funds tracked by Wall St. Rank held Akamai as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.